Five Prime Therapeutics Prices 4.8M Share IPO at $13.00/Share

Five Prime Therapeutics, Inc. FPRX (Five Prime) announced today the pricing of its initial public offering of 4,800,000 shares of its common stock at a price of $13.00 per share for an aggregate offering of $62.4 million, before underwriting discounts, commissions and expenses. All of the shares of common stock are being offered by Five Prime. In addition, Five Prime has granted the underwriters a 30-day option to purchase up to 720,000 additional shares of common stock at the initial public offering price to cover over-allotments, if any. The shares of Five Prime's common stock will trade on the NASDAQ Global Market under the symbol "FPRX" beginning on September 18, 2013. The offering is expected to close on September 23, 2013, subject to customary closing conditions. Jefferies LLC, BMO Capital Markets and Wells Fargo Securities, LLC are acting as joint book-running managers and Guggenheim Securities, LLC is acting as a co-manager for the offering. See full press release